Vijaya Diagnostics IPO - Healthy Outlook, Steady Cash Generation Augur Well: Reliance Securities
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Reliance Securities' IPO Report
Vijaya Diagnostic Centre Ltd., incorporated in June 2002, is the largest integrated diagnostic chain in southern India.
The company offers a one-stop solution for pathology and radiology testing services to its customers through extensive operational network, which consists of 80 diagnostic centres and 11 reference laboratories across 13 cities/towns in Telangana, Andhra Pradesh, National Capital Region and Kolkata.
It provides value-added services such as home collection of specimens/samples, house calls and various delivery of test reports via different modes such as (diagnostic centres, SMS, email and web portal).
The company's financial performance has been impressive over the two years.
While its revenue clocked 13% compound annual growth rate over FY19-FY21, net profit recorded a robust 36% CAGR during the same period.
Click on the attachment to read the full IPO report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.